Please provide your email address to receive an email when new articles are posted on . Injection in the subretinal space, currently performed or investigated for several cell-based and gene therapy ...
Please provide your email address to receive an email when new articles are posted on . FORT LAUDERDALE, Fla. — Best practices for safe subretinal delivery of gene therapy were presented at the Retina ...
Ophthalmologists from the Zhongshan Ophthalmic Center of Sun Yat-sen University reached a milestone on Sunday by successfully conducting the world's first remote robotic subretinal injection surgery.
LONDON--(BUSINESS WIRE)--Gyroscope Therapeutics Limited, a clinical-stage retinal gene therapy company, today announced that the first surgery using its proprietary Orbit™ Subretinal Delivery System ...
In experiments with rats, pigs and monkeys, Johns Hopkins Medicine researchers have developed a way to deliver sight-saving gene therapy to the retina. If proved safe and effective in humans, the ...
Clinical Trials Arena on MSN
First patient treated in trial of Beacon Therapeutics’ XLRP treatment
Beacon Therapeutics has treated the first patient in its open-label LANDSCAPE trial of the potential gene therapy, laru-zova ...
In experiments with rats, pigs and monkeys, Johns Hopkins Medicine researchers have developed a way to deliver sight-saving gene therapy to the retina. If proved safe and effective in humans, the ...
The PRIMA system is a subretinal implant designed to restore central vision in GA patients by replacing failed photoreceptors ...
In experiments with rats, pigs and monkeys, researchers have developed a way to deliver sight-saving gene therapy to the retina. If proved safe and effective in humans, the technique could provide a ...
When the FDA approved Spark Therapeutics’ Luxturna in December 2017, gene therapy became a household concept. Chatter about gene therapy curing blindness became hot fodder at dinner tables and ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果